Wednesday, March 30, 2022

FDA MedWatch - One Lot of IDArubicin Hydrochloride Injection USP, 5 mg/5 mL by Teva

Recall - Due to Presence of Particulate Matter

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment